Abstract
Antimicrobial resistance (AMR) surveillance systems involve multiple stakeholders and multilevel standard operating procedures, which increase in complexity with further integration of the One Health (OH) concept. AMR is a OH challenge. It is crucial for the success of an AMR surveillance system to evaluate its performance in meeting the proposed objectives, while complying with resource restrictions. The OH-EpiCap tool was created to evaluate the degree of compliance of hazard surveillance activities with essential OH concepts across there dimensions: organization, operational activities, and impact of the OH surveillance system.
To present feedback on the application of the OH-EpiCap from a user’s perspective, the tool was used to evaluate nine national AMR surveillance systems, each with different monitoring contexts and objectives. The OH-EpiCap tool was assessed using the updated CoEvalAMR methodology. This methodology evaluates the content themes and functional aspects of the tool in a standardized way, while it also captures the user’s subjective experiences in using the tool via a strengths, weaknesses, opportunities, and threats (SWOT) approach.
The results of the evaluation of the OH-EpiCap are presented and discussed. The OH-EpiCap is an easy-to-use tool, which can facilitate a fast macro-overview of the application of the OH concept to a surveillance activity, when used by specialists in the matter, serving as a basis for the discussion of possible adaptations of AMR surveillance activities, or targeting areas that may be further investigated using other pre-established tools.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Canadian Institutes for Health Research through the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
